Talks
Capivasertib in mBC
December 20, 2023
Share
Ev Pembro FDA approval
December 17, 2023
Share
Belzutifan FDA approval RCC
December 15, 2023
Share
HER2 positive mUC
December 8, 2023
Share
Triplet therapy in mRCC
December 1, 2023
Share
Pembro in Cholangiocarcinomq
November 30, 2023
Share
Ultraprocessed food and risk of cancer
November 30, 2023
Share
Pembro plus Chemo GEJ cancers
November 28, 2023
Share
Fruquintinib in mCRC
November 28, 2023
Share
Ropotrectinib FDA APPROVAL
November 28, 2023
Share
FDA Approval for Enza in nmCSPS with BCR
November 23, 2023
Share
Erdafitinib Vs Chemo in mUC
November 23, 2023
Share
ENZA-p
November 23, 2023
Share
Pembrolizumab in RCC
November 2, 2023
Share
LU177PSMA
October 31, 2023
Share
PSMAfore
October 31, 2023
Share
Erdafitinib
October 30, 2023
Share
Erdafitinib or Pembro in FGFR mUC
October 30, 2023
Share
THOR Cohort 1: Erda in mUC
October 30, 2023
Share
Nivolumab plus Gem-Cis in Advanced UC
October 28, 2023
Share
EV PEMBRO in mUC
October 23, 2023
Share
Erdafitinib in NMIBC
October 23, 2023
Share
Prophylactic RT
October 3, 2023
Share
LEAP 011- Lenvatinib and Pembro in mUC
October 1, 2023
Share
Gut Microbiota and Immunotherapy
September 29, 2023
Share
CABINET TRIAL
September 29, 2023
Share
Exercise and Lynch syndrome
September 29, 2023
Share
Thromboprophylaxis in cancer patients
September 27, 2023
Share
Primary VTE prophylaxis in Cancer pts
September 27, 2023
Share
Rogarafenib+Nivo FOLFOX in E&GEJ cancers
September 25, 2023
Share
PROpel mCRPC 2
September 25, 2023
Share
PrROpel mCRPC
September 25, 2023
Share
Agnostic approvals in oncology 2
September 16, 2023
Share
Agnostic Drug approvals in oncology
September 16, 2023
Share
Steroids and immunotherapy response
August 30, 2023
Share
Divarasib in KRAS G12C mutant tumors
August 30, 2023
Share
PROSPECT TRIAL-NEOADJUVANT FOLFOX
August 29, 2023
Share
GLOW TRIAL
August 29, 2023
Share
SPOTLIGHT TRIAL
August 29, 2023
Share
HER-RAM Trial
August 24, 2023
Share
DESTINY GASTRIC 02 trial
August 24, 2023
Share
ATORVASTATIN and Anthracyclines
August 24, 2023
Share
PEMBRO LEN In Non clear cell RCC
August 16, 2023
Share
EVEREST TRIAL
August 16, 2023
Share
NET-02 3/3
July 29, 2023
Share
NET-02 2
July 29, 2023
Share
NET-02 TRIAL
July 29, 2023
Share
EV+ Pembro in mUC 2
July 24, 2023
Share
EV+Pembro in mUC
July 24, 2023
Share
ZUMA-7
July 20, 2023
Share
ZUMA-7 5-year data
July 20, 2023
Share
JAVELIN BLADDER TRIAL 2
July 13, 2023
Share
JAVELIN BLADDER TRIAL
July 13, 2023
Share
TRINTON-3 trial
July 2, 2023
Share
Magnitude Trial: Niraparib in mCRPC 2
June 26, 2023
Share
MAGNITUDE TRIAL: Niraparib inmCRPC
June 26, 2023
Share
SWOG S1826: Nivo+ AVD in cHL
June 21, 2023
Share
FDA approval for Glofitamab in R/R DLBCL
June 17, 2023
Share
Duration of ICI in Advanced NSCLC
June 15, 2023
Share
Luspatercept in Low risk MDS
June 14, 2023
Share
Close button
Why are you reporting this TALK?